Search - tctmd.com

Displaying 61 - 80 of 125

Sort: Relevancy | Date

Presentation JIM 2018

Prime Time For..."Protected TAVI"

Presenter: Martin B. Leon

February 23, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for January 2018

Shelley Wood

January 31, 2018

Presentation

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Presenter: John D. Carroll,

October 06, 2017

Presentation CDM 2017

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Presenter: John D. Carroll

October 06, 2017

News Conference News VIVA 2017

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

L.A. McKeown

September 15, 2017

Presentation LAA 2017

Left Atrial Appendage Occlusion as Adjunctive Therapy

Presenter: Amar Krishnaswamy

July 21, 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2017

Shelley Wood

July 03, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

News Daily News

FDA Clears Sentinel Cerebral Protection Device for Use During TAVR

Shelley Wood

June 05, 2017

News Conference News EuroPCR 2017

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

Michael O'Riordan

May 26, 2017

News Conference News ACC 2017

Post-TAVR, Nearly a Quarter of Patients Show New Signs of Silent Cerebral Microbleeds on MRI

Caitlin E. Cox

March 20, 2017

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

‘Promising’ SENTINEL Cerebral Protection in TAVR Collects Debris but Misses Primary Endpoint

News Conference News TCT 2016

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Shelley Wood

November 01, 2016

News Conference News PCR London Valves 2016

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Shelley Wood

September 22, 2016

News Daily News

TAVR 伴随中风风险：PARTNER 研究深入审查和 CoreValve 数据揭示了机遇和未知

Shelley Wood

September 13, 2016

News Daily News

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Shelley Wood

September 13, 2016

News Daily News

Riesgo de ACV con TAVR: Una Revisión en Profundidad de los Datos del PARTNER y CoreValve Revela Oportunidades e Incógnitas

Shelley Wood

September 13, 2016

Presentation

Timing, Risk Factors, Outcomes of Stroke, TIA after TAVR: PARTNER Trial

Presenter: Samir Kapadia

September 12, 2016

Presentation

Neurological Events Following TAVR and Their Predictors: CoreValve Trials

Presenter: Neal Kleiman

September 12, 2016

News Daily News

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Yael L. Maxwell

August 10, 2016

Advertisement

Prime Time For..."Protected TAVI"

TCTMD’s Top 10 Most Popular Stories for January 2018

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

Left Atrial Appendage Occlusion as Adjunctive Therapy

TCTMD’s Top 10 Most Popular Stories for June 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

FDA Clears Sentinel Cerebral Protection Device for Use During TAVR

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

Post-TAVR, Nearly a Quarter of Patients Show New Signs of Silent Cerebral Microbleeds on MRI

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

TAVR 伴随中风风险：PARTNER 研究深入审查和 CoreValve 数据揭示了机遇和未知

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Riesgo de ACV con TAVR: Una Revisión en Profundidad de los Datos del PARTNER y CoreValve Revela Oportunidades e Incógnitas

Timing, Risk Factors, Outcomes of Stroke, TIA after TAVR: PARTNER Trial

Neurological Events Following TAVR and Their Predictors: CoreValve Trials

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content